Bosnia and Herzegovina vs Italy: Percentage of bloodstream infection due to methicillin-resistant
Bosnia and Herzegovina
26.5%
in 2022
Italy
30.6%
in 2022
Bosnia and Herzegovina rank
25th
Italy rank
22nd
Percentage of bloodstream infection due to methicillin-resistant over time
- Bosnia and Herzegovina
- Italy
How they compare
Italy currently reports 30.6% against 26.5% in Bosnia and Herzegovina, a difference of 4.1%.
That makes Italy's figure about 1.2 times Bosnia and Herzegovina's.
Across all 5 years both countries report, Italy has been ahead every year.
Bosnia and Herzegovina ranks 25th and Italy ranks 22nd of 50 countries.
Italy has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Bosnia and Herzegovina | Italy | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 13.4% | 36.4% | 22.9% | Italy |
| 2020s | 23.5% | 32.7% | 9.2% | Italy |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher percentage of bloodstream infection due to methicillin-resistant, Bosnia and Herzegovina or Italy?
- Italy, at 30.6% against 26.5% in Bosnia and Herzegovina as of 2022.
- What is the difference in percentage of bloodstream infection due to methicillin-resistant between Bosnia and Herzegovina and Italy?
- 4.1%, with Italy ahead.
- How many years of comparable data are there for Bosnia and Herzegovina and Italy?
- 5 years are reported by both, from 2018 to 2022.
- How do Bosnia and Herzegovina and Italy rank globally for percentage of bloodstream infection due to methicillin-resistant?
- Bosnia and Herzegovina ranks 25th and Italy ranks 22nd of 50 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.